Rapid Micro Biosystems
RPID
24 hedge funds and large institutions have $21.9M invested in Rapid Micro Biosystems in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3.23% less ownership
Funds ownership: 62.72% → 59.49% (-3.2%)
23% less funds holding
Funds holding: 31 → 24 (-7)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
37% less capital invested
Capital invested by funds: $34.5M → $21.9M (-$12.6M)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
+$506K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$50.3K |
| 3 |
Millennium Management
New York
|
+$8.81K |
| 4 |
BlackRock
New York
|
+$7.89K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$343 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$997K |
| 2 |
ABG
Ally Bridge Group
New York
|
-$300K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$181K |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$165K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$76.6K |
RPID Hedge Fund Activity: Q2 2023 in Review
24 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q2 2023, worth a combined $21.9M — down 37% from $34.5M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of RPID and 2 opened new positions — a net loss of 7 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Glenview Capital Management, adding an estimated $506K. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $997K sold.
- 24 institutional investors held Rapid Micro Biosystems (RPID) as of Q2 2023, down from 31 in Q1 2023.
- Funds reported $21.9M of Rapid Micro Biosystems stock for Q2 2023, down 37% quarter-over-quarter.
- 2 funds opened new Rapid Micro Biosystems positions in Q2 2023 and 9 closed out, a net change of -7 holders.
- The largest Rapid Micro Biosystems buyer in Q2 2023 was Glenview Capital Management, an estimated $506K added.
- The largest Rapid Micro Biosystems seller in Q2 2023 was T. Rowe Price Associates, an estimated $997K sold.
Based on aggregated 13F filings for Q2 2023.